Human Spinal Cord Modulation System

A Novel Medical Technology for the Selective Stimulation of Targeted Spinal Cord Pathways

At present, less than 1% of the neural structures within the spinal cord can be modulated using existing epidural spinal cord stimulators. This leaves many patients with very limited options for overcoming motor deficits and spasticities caused by spinal cord injuries, intractable pain from failed back surgery and phantom limb syndromes, and a variety of other severe neurological conditions. The Human Spinal Cord Modulation System (HSCMS) is being developed by a global research and development consortium that seeks to transform this situation into one with much improved outcomes. Dr. Matthew Howard, professor and head of the Department of Neurosurgery at the University of Iowa, is the research team leader. Dr. Howard is a senior neurosurgeon-scientist with extensive experience directing large-scale basic and applied research programs. He directs a long-standing, NIH-funded human neurophysiology research laboratory and is a prolific medical device inventor, with 27 issued US medical device patents. Other HSCMS group leaders include senior scientists, academic physicians, and medical device industry specialists at leading institutions throughout the US, Europe, and Australia. Collectively, the consortium members have all of the specialized skills and experience required to bring the HSCMS concept to clinical fruition. A prototype device designed for eventual use in patients is now undergoing rigorous testing in preparation for the regulatory evaluations needed to begin a human pilot trial.

Our lab is centered in and administered by the Department of Neurosurgery at the University of Iowa Roy J. and Lucille A. Carver College of Medicine.

For more information or to provide support please contact:

Dr. Matthew Howard
Professor and Chair of Neurosurgery
Carver College of Medicine
University of Iowa
(319) 356-8468